Morphotonics raised €40M in a Series B round announced on September 22, 2026. nanoimprint technology.
nanoimprint technology.
Morphotonics, based in Veldhoven, Netherlands, announced €40M in Series B financing on September 22, 2026.
Participants include Innovation Industries, 3M Ventures, BOM, Invest-NL, the European Innovation Council (EIC) Fund.
AI medical assistants and clinical workflow software for healthcare providers.
AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.